Skip to main content

Find Clinical Trials

Home
Conditions
Skin Diseases

Clinical trial condition

Skin Diseases

Explore clinical trials studying Skin Diseases. Study availability and eligibility vary by location and protocol.

23,059 public trials 3,730 recruiting studies

Refine in advanced search Browse all conditions

Skin Diseases trial results

Recruiting

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

NCT07229313

Conditions: Adnexal Diseases, Advance Solid Tumors, Breast Diseases, +59 more
Locations: Kivu Trial Site Santa Monica, California, United States

Kivu Trial Site Camperdown, New South Wales, Australia

Kivu Trial Site Sydney, New South Wales, Australia

Kivu Trial Site Brisbane, Queensland, Australia

View Trial Details

Recruiting

Phase 1 Dose Escalation and Expansion Study of PRAME T Cell Receptor (TCR) Engineered NK Cells in Participants With Recurrent and/or Refractory Melanoma (PRAMETIME-Mel)

NCT06660420

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +12 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

A Study to Evaluate Comparative Efficacy and Safety of Guselkumab in High-dose and Extended-interval Versus Standard-dose in Chinese Participants of Moderate-to-severe Plaque Psoriasis

NCT07532486

Conditions: Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations: The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

NCT06434363

Conditions: Autoimmune Diseases, Autoimmune Disorders, Bronchial Diseases, +27 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

The University of Texas Health Science Center at Houston Houston, Texas, United States

View Trial Details

Recruiting

ROS-scavenging Amino Acid-derived Lipids for the Prevention and Treatment of Radiation Dermatitis in Patients With Head and Neck Cancer

NCT07081074

Conditions: Dermatitis, Radiation Dermatitis, Radiation Injuries, +4 more
Locations: West China Hospital, Sichuan University Chengdu, Sichuan, China

View Trial Details

Recruiting

ROS-Scavenging Nanozyme Combined With Thermotherapy Alleviate Radiation Dermatitis in Patients With Head and Neck Cancer

NCT07086638

Conditions: Dermatitis, Radiation Dermatitis, Radiation Injuries, +4 more
Locations: Sichuan University West China Hospital Chengdu, Sichuan, China

View Trial Details

Recruiting

Phase 2 Study of Lesigercept in Adult Patients With Chronic Spontaneous Urticaria Who Are Inadequately Controlled by H1-Antihistamines

NCT07415551

Conditions: Allergic Diseases, Chronic Disease, Chronic Spontaneous Urticaria (CSU), +11 more
Locations: Diagnostic & Consultative Centre Ascendent EOOD Sofia, Bulgaria

UMHAT "Aleksandrovska" Sofia, Bulgaria

Medical Center Hera EOOD Sofia, Bulgaria

UMHATEM "N. I. Pirogov" Sofia, Bulgaria

View all 30 locations

View Trial Details

Recruiting

NO Re-excision MelanomA - NORMA 2

NCT07530887

Conditions: Melanoma, Melanoma (Skin Cancer), Neoplasms, +10 more
Locations: Jeroen Bosch Ziekenhuis 's-Hertogenbosch, Netherlands

Noordwest Ziekenhuisgroep Alkmaar, Netherlands

Flevoziekenhuis Almere Stad, Netherlands

Antoni van Leeuwenhoek Amsterdam, Netherlands

View all 21 locations

View Trial Details

Recruiting

Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial

NCT04693377

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +66 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer

NCT05042687

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details